Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026)
Alcon (ALC) posted Net Income towards Common Stockholders of $415.0 million for Q1 2026, up 8.64% on a QoQ basis from $382.0 million in Q4 2025.
Analysis
Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Alcon has reported Net Income towards Common Stockholders for 11 years, with the latest figure at $415.0 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders changed N/A year-over-year to $415.0 million in Q1 2026; TTM through Jun 2026 was $1.2 billion, a 2.67% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, changed 0.4% from the prior year.
- Net Income towards Common Stockholders was $415.0 million for Q1 2026 at Alcon, up from $382.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $415.0 million in Q1 2026, with the low at -$91.0 million in Q4 2023.
- Average Net Income towards Common Stockholders over 5 years is $251.2 million, with a median of $254.5 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders slumped 360.0% in 2023, then jumped 494.51% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at $35.0 million in 2022, then tumbled by 360.0% to -$91.0 million in 2023, then surged by 494.51% to $359.0 million in 2024, then rose by 6.41% to $382.0 million in 2025, then grew by 8.64% to $415.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $415.0 million (Q1 2026), $382.0 million (Q4 2025), and $394.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 249.10 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 383.43 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 201.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 415.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 394.00 Mn |
| Jun 30, 2025 | 176.00 Mn |
| Dec 31, 2024 | 359.00 Mn |
| Sep 30, 2024 | 402.00 Mn |
| Jun 30, 2024 | 223.00 Mn |
| Mar 31, 2024 | 387.00 Mn |
| Dec 31, 2023 | -91.00 Mn |
| Sep 30, 2023 | 272.00 Mn |
| Jun 30, 2023 | 257.00 Mn |
| Mar 31, 2023 | 252.00 Mn |
| Dec 31, 2022 | 35.00 Mn |
| Sep 30, 2022 | 178.00 Mn |
| Jun 30, 2022 | 146.00 Mn |
| Mar 31, 2022 | 232.00 Mn |
| Dec 31, 2021 | 143.00 Mn |
| Sep 30, 2021 | -48.00 Mn |
| Jun 30, 2021 | 231.00 Mn |
| Mar 31, 2021 | 134.00 Mn |